We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
+25.52%
1 Year Est. Return
+31.98%
3 Year Est. Return
+79.76%
5 Year Est. Return
+101.81%
10 Year Est. Return
+512.72%
AUM
$9.53B
AUM Growth
+$1.89B
Cap. Flow
+$270M
Cap. Flow %
2.83%
Top 10 Hldgs %
11.36%
Holding
417
New
23
Increased
169
Reduced
161
Closed
41

Top Buys

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$39.8M
2
DAVA icon
Endava
DAVA
+$35.7M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$32.6M
4
HALO icon
Halozyme
HALO
+$30.3M
5
AZTA icon
Azenta
AZTA
+$29M

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$67.2M
2
VRTU
Virtusa Corporation
VRTU
+$45.8M
3
SITE icon
SiteOne Landscape Supply
SITE
+$40.6M
4
PODD icon
Insulet
PODD
+$37.5M
5
FIVE icon
Five Below
FIVE
+$25.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.76%
2 Technology 15.98%
3 Industrials 14.75%
4 Consumer Discretionary 13.32%
5 Financials 12.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCTY icon
26
Paylocity
PCTY
$7.7B
$62.9M 0.66%
305,242
-25,646
-8% -$4.93M
ACHC icon
27
Acadia Healthcare
ACHC
$2.9B
$62.4M 0.66%
1,242,285
+482,313
+63% +$19.2M
AMT icon
28
American Tower
AMT
$79B
$62M 0.65%
276,315
+1,370
+0.5% +$318K
AVNT icon
29
Avient
AVNT
$4.17B
$61.7M 0.65%
1,531,574
-5,397
-0.4% -$190K
BIPC icon
30
Brookfield Infrastructure
BIPC
$4.92B
$60.7M 0.64%
1,259,633
+19,898
+2% +$843K
CTLT
31
DELISTED
CATALENT, INC.
CTLT
$60.7M 0.64%
582,875
+674
+0.1% +$65.3K
DAVA icon
32
Endava
DAVA
$160M
$59.4M 0.62%
774,425
+527,795
+214% +$35.7M
KWR icon
33
Quaker Houghton
KWR
$2.94B
$58.7M 0.62%
231,588
-37,115
-14% -$8.38M
SF
34
Stifel
SF
$12.7B
$58.5M 0.61%
1,737,939
+158,722
+10% +$4.71M
IR icon
35
Ingersoll Rand
IR
$33B
$57.5M 0.6%
1,262,137
+767
+0.1% +$31.7K
DOC
36
DELISTED
PHYSICIANS REALTY TRUST
DOC
$57.2M 0.6%
3,212,946
+392,218
+14% +$7.02M
RPM icon
37
RPM International
RPM
$14.9B
$56.8M 0.6%
625,863
-115,976
-16% -$10.2M
MTSI icon
38
MACOM Technology Solutions
MTSI
$22.9B
$56.6M 0.59%
1,028,516
-4,166
-0.4% -$178K
EBS icon
39
Emergent Biosolutions
EBS
$228M
$56.4M 0.59%
629,181
+166,325
+36% +$15.3M
TME icon
40
Tencent Music
TME
$14.3B
$54.9M 0.58%
2,852,479
+127,825
+5% +$2.08M
ABCB icon
41
Ameris Bancorp
ABCB
$5.92B
$53.5M 0.56%
1,405,368
+279,990
+25% +$9.06M
WAL icon
42
Western Alliance Bancorporation
WAL
$8.89B
$53.4M 0.56%
891,385
+9,893
+1% +$482K
BIO icon
43
Bio-Rad Laboratories Class A
BIO
$9.53B
$53.4M 0.56%
91,555
+38
+0% +$21.6K
PNFP icon
44
Pinnacle Financial Partners Inc
PNFP
$16B
$53.4M 0.56%
828,460
+3,577
+0.4% +$184K
TTC icon
45
Toro Company
TTC
$9.41B
$52.8M 0.55%
556,871
+433
+0.1% +$38.3K
BFAM icon
46
Bright Horizons
BFAM
$3.76B
$52.6M 0.55%
304,128
+1,321
+0.4% +$216K
SUI icon
47
Sun Communities
SUI
$14.5B
$52M 0.55%
342,538
+40,952
+14% +$5.93M
BAH icon
48
Booz Allen Hamilton
BAH
$9.45B
$50.8M 0.53%
582,182
-136,573
-19% -$11.6M
ABBV icon
49
AbbVie
ABBV
$442B
$50.6M 0.53%
472,113
-3,307
-0.7% -$318K
NDSN icon
50
Nordson
NDSN
$17.3B
$50.5M 0.53%
251,386
-91
-0% -$18.3K
1
2
3 4 5

Similar funds

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
DWM
Dynasty Wealth Management St. Petersburg, Florida $11.5B AUM 15.23% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
VA
Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return

GW&K Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, GW&K Investment Management held 417 positions worth $9.53B, up 25% from $7.64B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

GW&K Investment Management's Q4 2020 filing shows 23 new, 169 increased, 161 reduced and 41 closed positions. Its largest new stake was Medpace: 315,843 shares worth $44M. The largest sale was QuidelOrtho, an estimated $67.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • GW&K Investment Management's largest Q4 2020 buy was Medpace: 315,843 shares worth $44M.
  • GW&K Investment Management added most to Endava in Q4 2020, an estimated $35.7M increase.
  • GW&K Investment Management's biggest Q4 2020 reduction was QuidelOrtho, cutting an estimated $67.2M.
  • GW&K Investment Management fully exited Aimmune Therapeutics in Q4 2020, selling an estimated $10.2M.
  • GW&K Investment Management's ten largest holdings make up 11% of its $9.53B portfolio in Q4 2020.
  • GW&K Investment Management opened 23 new positions and closed 41 in Q4 2020.
  • GW&K Investment Management's portfolio value rose 25% quarter-over-quarter to $9.53B.

Based on GW&K Investment Management's 13F filing for Q4 2020, filed 5 Feb 2021.